Anticancer drugs designed by mother nature: Ancient drugs but modern targets

Current Pharmaceutical Design

Volumn 13, Issue 33, 2007, Pages 3400-3416

  Ichikawa, Haruyo ^a   NAkamura, Yutaka ^b   Kashiwada, Yoshiki ^c   Aggarwal, Bharat B ^d  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Department of Natural Medicine ^*  (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Ancient drug; Inflammation; NF B; NF B inhibitor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; APOPTOSIS INHIBITOR; AYURVEDIC DRUG; CELL CYCLE PROTEIN; CHEMOKINE; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; ELLIPTICINE; ELLIPTINIUM; ETOPOFOS; FLAVONOID; GREEN TEA EXTRACT; GROWTH FACTOR; HOMOHARRINGTONINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAMPO; LIPOXYGENASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NATURAL PRODUCT; NITRIC OXIDE SYNTHASE INHIBITOR; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; PROTEIN P53; RESVERATROL; STAT PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AYURVEDA; CHINESE MEDICINE; CLINICAL TRIAL; DNA METHYLATION; DRUG DESIGN; DRUG DETERMINATION; DRUG STRUCTURE; DRUG TARGETING; HERBAL MEDICINE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; STRUCTURE ACTIVITY RELATION; TRADITIONAL MEDICINE; TUMOR VASCULARIZATION;

EID: 36749015617     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207782360492     Document Type: Review

References (145)

1. Kong JM, Liu Y. COVER STORY: New Bioactive Compounds from Herbs In Innovation, vol. 6; 2006.
2. Aggarwal BB. Nuclear factor-kappaB: The enemy within. Cancer Cell 2004; 6: 203-8.
3. Sharma PV Ed. Charaka samhita. Varanasi: Choukhamba Orientalia 1981.
4. Murthy KRS (Ed.). Susruta. Sushruta, Samhita, (700 BC). Varanasi: Choukhamba Orientalia 2005.
5. Subbarayappa BV. The roots of ancient medicine: An historical outline. J Biosci 2001; 26: 135-43.
6. Balunas, MJ Kinghorn AD. discovery from medicinal plants. Life Sci 2005; 78:431-41.
7. Muller-Kuhrt L. Putting nature back into drug discovery. Nat Biotechnol 2003; 21: 602.
8. Hohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tjian R, Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 1987; 238: 1386-92.
9. Eferl R, Wagner EF. AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 2003; 3: 859-68.
10. Dong Z. Effects or food factors on signal transduction pathways. Biofactors 2000; 12: 17-28.
11. Lagarrigue S, Chaumontet C, Heberden C, Martel P, Gaillard-Sanchez I. Suppression of oncogene-induced transformation by quercetin and retinoic acid in rat liver epithelial. cells. Cell Mol Biol Res 1995; 41: 551-60.
12. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000; 164: 6509-19.
13. Wan SS, Keum YS, Seo HJ, Surb YJ. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 2002; 35: 33742.
14. Hergenhahn M, Soto U, Weninger A, Polack A, Hsu CH, Cheng AL, Rost F. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Bair virus BZLF1 transcription in Raji DR-LUC cells. Mol Carcinog 2002; 33: 137-45.
15. Han SS, Keum YS, Soo HJ, Chun KS, Lee SS, Surh YJ. Capsaicin suppresses phorbol ester-induced activatiomof NF-kappaB/Re1 and AP-1 transcription factors in mouse epidermis. Cancer Lett 2001; 164: 119-26.
16. Manna SK, Sah NK, Newman RA, Cisneros A, Aggarwal BB. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res 2000; 60: 3838-47.
17. Chainy GB, Manna SK, Chaturvedi MK Aggarwal BB. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. Oncogene 2000; 19: 2943-50.
18. Manna SK, Gad YP, Mukhopadhyay A, Aggarwal BB. Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein- 1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone. Biochem Pharmacol 1999; 57: 763-74.
19. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993; 7: 812-21.
20. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther 2002; 1: 226-31.
21. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M, Aggarwal BB. Curcumin-induced suppression of cell proliferation coffelates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002; 21: 8852-61.
22. Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM, et al. Resveratrol blocks interleukin- 1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003; 102: 987-95.
23. Li M, Zhang Z, Hill DL, Chen X, Wang H, Zhang R. Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. Cancer Res 2005; 65: 8200-8.
24. Jakabikova J, Bao Y, Sedlak J. Isothiocyanates induce cell cycle affest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines. Anticancer Res 2005; 25: 3375-86.
25. Takagaki N, Sowa Y, Oki T, Nakanishi R, Yogosawa S, Sakai T. Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway. Int J Oncol 2005; 26: 185-9.
26. Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. Clin Cancer Res 2002; 8: 3512-9.
27. Aggarwal BB. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol. 2003; 3: 745-56.
28. Moore RJ, Owens DM, Stamp G, Amott C, Burke F, East N, et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 1999; 5: 828-31.
29. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM. Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro. Science 1985; 230: 943-5.
30. Giri DK, Aggarwal BB. Constitutive activation of NF-kappaB causes resistance to spoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem 1998; 273: 14008-14.
31. Aggarwal BB, Schwarz L, Hogan ME, Rando RE Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Res 1996; 56: 5156-64.
32. Tucker SJ, Rae C, Littlejohn AF, Paul A, MacEwan DJ. Switching leukemia cell phenotype between fife and death. Proc Natl Acad Sci USA 2004; 101: 12940-5.
33. Estrov Z, Kurzrock R, Pocsik E, Pathak S, Kantarjian HM, Zipf TF, et al. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J Exp Med 1993; 177: 763-74.
34. Sugarman BJ, Lewis GD, Eessalu TE, Aggarwal BB, Shepard HM. Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res 1987; 47: 780-6.
35. Chapekar MS, Huggett AC, Thorgeirsson SS. Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor beta 1, and recombinant tumor necrosis factor alpha, in normal and neoplastic cells. Exp Cell Res 1989; 185: 247-57.
36. Borset M, Waage A, Brekke OL, Helseth E. TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma. cell line. Eur J Haematol 1994; 53: 31-7.
37. Hsu SM, Hsu PL. Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Stemberg cells. Comparison with effects of phorbol ester and retinoic acid. Am J Pathol 1990; 136: 181-9.
38. Shishoda S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005; 70: 700-13.
39. Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 2001; 60: 528-33.
40. Surh YJ, Park KK, Chun KS, Lee LJ, Lee E, Lee SS. Anti-tumor-promoting activities of selected pungent phenolic substances present in ginger. J Environ Pathol Toxicol Oncol 1999; 18: 131-9.
41. Kowalski J, Samojedny A, Paul M, Pietsz G, Wilczok T. Effect of apigenin, kaenipferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Pharmacol Rep 2005; 57: 390-4.
42. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-80.
43. Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: Its role in prevention and therapy. Biochem Pharmacol 2002; 64: 883-8.
44. Alessi DR, Andjelkovic, K Caudwell B, Cron P, Morrice N, Cohen P, et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996; 15: 6541-51.
45. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, et al. Involvement of P13K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy. Leukemia 2003; 17: 590-603.
46. Clarke RB. p27KIP1 phosphorylation by PKB/Akt leads to poor breast cancer prognosis. Breast Cancer Res 2003; 5: 162-3.
47. Ozes ON, Mayo LD, Gustin TA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999; 401: 82-5.
48. Romashkova JA, Makamv SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999; 401: 86-90.
49. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318-21.
50. Rommel C, C e BA, Zimmermann S, Nunez L, Rossman R, Reid K, et al. Differentiation stage specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999; 286: 1738-41.
51. Li Y, Sarkar FH. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 2002; 8: 2369-77.
52. Chinni SR, Sarkar FH. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res 2002; 8: 1228-36.
53. Shishodia S, Aggarwal BB. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Oncogene 2006; 25: 1463-73.
54. Aggarwal S, Ichikawa H, Takada Y, Sandur SY, Shishodia S, Aggarwal BB. Curcumin (diferuloyhnethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 2006; 69: 195-206.
55. Tang FY, Nguyen N, Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer 2003; 106: 871 -8.
56. Huang C, Li J, Song L, Zhang D, Tong Q, Ding M, et al. Black raspberry extracts inhibit benzo(a)pyrene diol-epoxide-induced activator protein 1 activation and VEGF transcription by targeting the phosphotidylinositol 3-kinase/Akt pathway. Cancer Res 2006; 66: 581-7
57. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523-6.
58. Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Imummol 1999; 93: 152-61.
59. Huang C, Ma WY, Goranson A, Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999; 20: 237-42.
60. Gupta SK, Patel MA, Joseph AD. Effects of chlorpromazine and epinephrine on blood-sugar of rabbits. Arch Int Pharmacodyn Ther 1960; 128: 82-8.
61. Hong C, Kim HA, Firestone GL, Bjeldanes LF. 3,3pm-Diindolyl-methane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002; 23: 1297-305.
62. Gu M, Dhanalakshmi S, Mohan S, Singh RP, Agarwal R. Silibinin inhibits ultraviolet B radiation-induced mitogenic and survival signaling, and associated biological responses in SKH-l mouse skin. Carcinogenesis 2005; 26: 1404-13.
63. Korutla L, Cheung JY, Mendelsohn J, Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 1995; 16: 1741-5.
64. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-801.
65. Hidaka H, Ishiko T, Furubashi T, Kamohara H, Suzuki S, Miyazaki M, et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: Impact on human pancreatic carcinoma cell growth by autoctine regulation. Cancer 2002; 95: 1206-14.
66. Shen F, Chen SJ, Dong XJ, Zhong H, Li YT, Cheng GF. Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells. J Asian Nat Prod Res 2003; 5: 151-7.
67. Ishikawa Y, Sugiyama H, Stylianou. E, Kitamura M. Bioflavonoid quercetin inhibits interleukin-1-induoed transcriptional expression of monocyte chemoattractant protein-1 in glomerular cells via suppression of nuclear factor-kappaB. J Am Soc Nephrol 1999; 10: 2290-6.
68. Porath D, Riegger C, Drewe J, Schwager J. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines. J Pharmacol Exp Ther 2005; 315: 1172-80.
69. Aneja R, Odoms K, Denenberg AG, Wong HR. Theaflavin, a black tea extract, is a novel anti-inflammatory compound. Crit Care Med 2004; 32: 2097-103.
70. Rimbach G, Weinberg PD, de Pascual-Teresa S, Alonso MG, Ewins BA, Turner R, et al. Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function. Biochim Biophys Acta 2004; 1670: 229-37.
71. Patel PS, Varney ML, Dave BJ, Singh RK. Regulation of constitutive and induced NF-kappaB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation. J Interferon Cytokine Res 2002; 22: 427-35.
72. Darnell JE, Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-21.
73. Darnell JE, Jr. STATs and gene Fe-gulation. Science 1997; 277: 1630-5
74. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995; 269: 81-3.
75. Grandis JR, Drenning SD, Cbakraborty A, Zhou MY, Zeng Q, Pitt AS, et al. Requirement of Stat3 but not Statl activation for epidermal growth factor receptor- mediated cell growth In vitro. J Clin Invest 1998; 102: 1385-92.
76. Carlesso N, Frank DA, Cniffm JD. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 1996; 183: 811-20.
77. Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, et al. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 1996; 88: 809-16.
78. Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 2003; 171: 3863-71.
79. Schnyder B, Schnyder-Candrian S, Panski A, Bommel H, Heim M, Duschl A, et al. Phytochemical inhibition of interleukin-4-activated Stat6 and expression of VCAM-1. Biochem Biophys Res Commun 2002; 292: 841-7.
80. Masuda M, Suzui M, Weinstein IB. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 200 1; 7: 4220-9.
81. Wung BS, Hsu MC, Wu CC, Hsieh CW. Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endodielial cells: Effects on the inhibition of STAT3 phosphorylation. Life Sci 2005; 78: 389-97.
82. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase 2: A molecular target for cancer prevention and treatment. Trends Pharmacol Sci 2003; 24: 96-102.
83. Baumann J, von Bruchbausen F, Wurm G. Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. Prostaglandins 1980; 20: 627-39.
84. Williams CA, Harborne JB, Geiger H, Hoult JR. The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties. Phytochemistry 1999; 51: 417-23.
85. Yasukawa K, Kaminaga T, Kitanaka S, Tai, Nunoura Y, Natori S, et al. 3 beta-p-hydroxybenzoyldehydrotumulosic acid from Poria cocos, and its anti-inflammatory effect. Phytochemistry 1998; 48: 1357-60.
86. Mutoh, Takahashi M, Fukuda K, Matsushima-Hibiya Y, Mutoh H, Sugimura T, et al. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 2000; 21: 959-63.
87. Chen YC, Shen SC, Chen LG, Lee TJ, Yang LL. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol 2001; 61: 1417-27.
88. Gerhauser C, Klimo K, Heiss E, Neumann I, Gamal-Eldeen A, Knauft J, et al. Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res 2003; 523-524: 163-72.
89. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 1999; 18: 6013-20.
90. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998; 273: 21875-82.
91. Hong J, Smith TJ, Ho CT, August DA, Yang CS. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism- of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol 2001; 62:1175-83.
92. MacCarrone M, Lorenzon T, Guerrieri P, Agro AF. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem 1999; 265: 27-34.
93. Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, et al. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 2004; 25: 1671-9.
94. Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol 1991; 42: 1673-81.
95. Reddy GR, Ueda N, Hada T, Sackeyfio AC, Yamamoto S, Hano Y, et al. A prenylflavone, artonin E, as arachidonate 5-lipoxygenase inhibitor. Biochem Pharmacol 1991; 41: 115-8.
96. Sekiya K, Okuda H. Selective inhibition of platelet lipoxygenase by baicalein. Biochem Biophys Res Commun 1982; 105: 1090-5.
97. Kim OK, Murakami A, Nakamura Y, Ohigashi H. Screening of edible Japanese plants for nitric oxide generation inhibitory activities in RAW 264.7 cells. Cancer Lett 1998; 125: 199-207.
98. Soliman KF, Mazzio FA. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc Soc Exp Biol Med 1998; 218: 390-7.
99. Ippoushi K, Azuma K, Ito H, Horie H, Higashio H. [6]-Gingerol inhibits nitric oxide synthesis in activated J774.1 mouse macrophages and prevents peroxynitrite-ioduced oxidation and nitration reactions. Life Sci 2003; 73: 3427-37.
100. Lin YL, Lin JK. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 1997; 52: 465-72.
101. Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 1999; 126: 673-80.
102. Chen YH, Dai HJ, Chang HP. Suppression of inducible nitric oxide production by indole and isothiocyanate derivatives from Brassica plants in stimulated macrophages. Planta Med 2003; 69: 696-700.
103. Chen Y, Yang L, Lee TJ. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem Pharmacol 2000; 59: 1445-57.
104. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M. Differential activation of ERK and JNK mitogen-activated protein, kinases by Raf-1 and MEKK. Science 1994; 266: 1719-23.
105. Cowley S, Paterson H, Kemp P, Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 373 cells. Cell 1994; 77: 841-52.
106. Bode AM, Dong Z. Signal transduction pathways: Targets for chemoprevention of skin cancer. Lancet Oncol 2000; 1: 181-8.
107. Bode AM, Dong Z. Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci STKE 2003; 2003: RE2.
108. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9: 726-35.
109. Cho JW, Park K, Kweon GR, Jang BC, Baek WK, Suh MH, et al. Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: P38 MAP kinase and JNK as potential upstream targets. Exp Mol Med 2005; 37: 186-92
110. Li Y, Li X, Sarkar FH. Gene expression profiles of 13C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarmy analysis. J Nutr 2003; 133: 1011-9.
111. Shih A, Davis FB, Lin HY, Davis PJ. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab 2002; 87: 1223 -32.
112. Katiyar SK, Afaq F, Azizuddin K, Mukhtar H. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol 2001; 176: 110-7.
113. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004; 22: 4632-42.
114. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998; 4: 376-83.
115. Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, Yao PL, et al. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol 2004; 65: 99-110.
116. Brakenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 2001; 15: 1798-800.
117. Shih SC, Claffey KP. Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression. Growth Factors 2001; 19:19-34
118. Bagli E, Stefaniotou M, Morbidelli L, Ziche M, Psillas K, Murphy C, et al. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity. Cancer Res 2004; 64: 7936-46.
119. Lamy S, Gingras D, Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 2002; 62: 381-5.
120. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloyhnethane) [corrected]. J Biol Chem 1995; 270: 24995-5000.
121. Shishodia S, Aggarwal BB. Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem 2004; 279:47148-58
122. Shishodia S, Majumdar S, Banerjee S, Aggarwal BB. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: Correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin DI. Cancer Res 2003; 63: 4375-83.
123. Takada Y, Aggarwal BB. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: Abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 2003; 171: 3278-86.
124. Kumar A, Dhawan S, Aggarwal BB. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothetial cells. Oncogene 1998; 17: 913-8.
125. Kim SO, Chun KS, Kundu JK, Surh YJ. Inhibitory efforts of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. Biofactors 2004; 21: 27-31.
126. Takada Y, Aggarwal BB. Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: Abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J Biol Chem 2004; 279: 4750-9.
127. Takada Y, Murakami A, Aggarwal BB. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 2005; 24: 6957-69.
128. Takada Y, Kobayashi Y, Aggarwal BB. Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem 2005; 280: 17203-12.
129. Takada Y, Andreeff M, Aggarwal BB. Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 2005; 106: 641-9.
130. Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Notr 1998; 128: 2334-40.
131. Geng Z, Rong Y, Lau BH. S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells. Free Radic Biol Med 1997; 23: 345-50
132. Kim GY, Kim JH, Ahn SC, Lee HJ, Moon DO, Lee CK Park YM. Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB. Immunology 2004; 113: 201-11.
133. Ahn KS, Sethi G, Aggarwal BB. Embelin, an Inhibitor of XIAP, Blocks Nuclear Factor-{kappa}B (NF-{kappa}B) Signaling Pathway Leading to Suppression of NF-{kappa}B-regulated Antiapoptotic and Metastatic Gene Products. Mol Pharmacol 2006.
134. Sethi G, Ahn KS, Sandur SK, Lin X, Chaturvedi MM, Aggarwal BB. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway. J Biol Chem 2006; 281: 23425-35.
135. Ichikawa H, Takada Y, Murakami A, Aggarwal BB. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products. J Immunol 2005; 174: 7383-92.
136. Ichikawa H, Nair MS, Takada Y, Sheeja DB, Kumar MA, Oommen OV, et al. Isodeoxyetephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-kappaB (nf-kappaB) activation and nf-kappaB-regulated gene expression. Clin Cancer Res 2006; 12: 5910-8.
137. Ichikawa H, Takada Y, Shishodia S, Jayaprakasam B, Nair MG, Aggarwal BB. Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression. Mol Cancer Ther 2006; 5: 1434-45.
138. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 2006; 4: 621-33.
139. Sandur SK, Ichikawa H, Sethi G, Ahn KS, Aggarwal BB. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem 2006; 281: 17023-33.
140. Shishodia S, Sethi G, Aggarwal BB. Curcumin: Getting back to the roots. Ann N Y Acad Sci 2005; 1056: 206-17.
141. Natarajan K, Singh S, Burke TR, Jr., Grunbeirger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific hibibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 1996; 93: 9090-5.
142. Chaturvedi MM, Kumar A, Darnay BG, Chainy GB, Agarwal S, Aggarwal BB. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J Biol Chem 1997; 272: 30129-34.
143. Ishihara S, Rumi MA, Ortega-Cava CF, Kazumori H, Kadowaki Y, Ishimura N, et al. Therapeutic targeting of toll-like receptors in gastrointestinal inflammation. Curr Pharm Des 2006; 12(32): 4215-28
144. Okamoto T, Sanda T, Asamitsu K. NF-kappaB signaling and carcinogenesis. Curr Pharm Des 2007; 13(5): 447-62.
145. Redell MS, Tweardy DJ. Targeting transcription factors for cancer therapy. Curr Pharm Des 2005; 11 (22): 2873-87.